Cargando…
Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia®
PURPOSE: The new active transcutaneous partially implantable osseointegrated system Cochlear™ Osia® System is indicated in case of conductive or mixed hearing loss (CHL/MHL) with a maximum average bone conduction hearing loss of 55 dB, or in single-sided deafness (SSD). The implant directly stimulat...
Autores principales: | Rauch, Ann-Kathrin, Wesarg, Thomas, Aschendorff, Antje, Speck, Iva, Arndt, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363475/ https://www.ncbi.nlm.nih.gov/pubmed/34792628 http://dx.doi.org/10.1007/s00405-021-07167-9 |
Ejemplares similares
-
Bone-anchored hearing system, contralateral routing of signals hearing aid or cochlear implant: what is best in single-sided deafness?
por: Jakob, Till F., et al.
Publicado: (2021) -
Is the cochlear implant a successful long-term solution for single-sided deaf and asymmetric hearing-impaired patients?
por: Speck, Iva, et al.
Publicado: (2020) -
Long-term results of cochlear implantation in children with congenital single-sided deafness
por: Rauch, Ann-Kathrin, et al.
Publicado: (2020) -
Pediatric morphometric study to guide the optimized implantation of the Osia(®) 2 implant system
por: Posta, Balint, et al.
Publicado: (2022) -
Hearing outcome after tympanoplasty type III
por: Tihanyi, A., et al.
Publicado: (2022)